Richard O'Kennedy Selected Research

Richard O'Kennedy Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2004
4	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2015
4	Prostatic Neoplasms (Prostate Cancer) 03/2017 - 03/2007
4	Inflammation (Inflammations) 08/2011 - 08/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 04/2018
3	Carcinoma (Carcinomatosis) 10/2018 - 01/2004
2	COVID-19 01/2022 - 10/2021
2	Heart Diseases (Heart Disease) 10/2021 - 04/2018
1	Myocardial Infarction 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Acute Coronary Syndrome 08/2019
1	Adenoma (Adenomas) 01/2019
1	Breast Neoplasms (Breast Cancer) 05/2018
1	Chronic Disease (Chronic Diseases) 04/2018
1	Asthma (Bronchial Asthma) 10/2016
1	Thrombosis (Thrombus) 01/2016
1	Infections 05/2015
1	Neuralgia (Stump Neuralgia) 09/2014
1	Pain (Aches) 09/2014
1	Protozoan Infections 07/2014
1	Coccidiosis 03/2011
1	Mastitis 02/2011
1	Atherosclerosis 08/2010
1	Hepatocellular Carcinoma (Hepatoma) 08/2010
1	Communicable Diseases (Infectious Diseases) 06/2010
1	Human Influenza (Influenza) 06/2010
1	Malaria 06/2010
1	Cystic Fibrosis (Mucoviscidosis) 02/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2004
1	Atrial Fibrillation 08/2004

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2007
5	Proteins (Proteins, Gene)FDA Link 10/2018 - 09/2014
4	Prostate-Specific Antigen (Semenogelase)IBA 03/2017 - 03/2007
3	AutoantibodiesIBA 01/2022 - 01/2015
3	EnzymesIBA 01/2019 - 08/2010
2	trans-crotonin (CTN)IBA 01/2022 - 10/2021
2	TroponinIBA 10/2021 - 08/2019
2	AntigensIBA 01/2019 - 01/2015
2	ImmunosorbentsIBA 01/2019 - 08/2010
2	Formaldehyde (Formol)FDA Link 10/2018 - 01/2015
2	halofuginoneIBA 05/2015 - 03/2011
1	Molecularly Imprinted PolymersIBA 08/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	human ERBB2 proteinIBA 05/2018
1	Fatty Acid-Binding ProteinsIBA 04/2018
1	GraphiteIBA 04/2018
1	Polysaccharides (Glycans)IBA 01/2017
1	LectinsIBA 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 12/2016
1	AntibodiesIBA 12/2016
1	Bispecific AntibodiesIBA 12/2016
1	Immune Checkpoint InhibitorsIBA 12/2016
1	Monoclonal AntibodiesIBA 10/2016
1	mepolizumabIBA 10/2016
1	Galectin 3 (LGALS3)IBA 01/2016
1	Galectin 1 (LGALS1)IBA 01/2016
1	von Willebrand FactorIBA 01/2016
1	diclazurilIBA 05/2015
1	toltrazurilIBA 05/2015
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2015
1	ParaffinIBA 01/2015
1	dihydroceramide desaturaseIBA 01/2015
1	Purinergic P2X ReceptorsIBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 09/2014
1	Peptides (Polypeptides)IBA 09/2014
1	incobotulinumtoxinA FDA Link 09/2014
1	CoccidiostatsIBA 07/2014
1	Nuclear Proteins (Protein, Nuclear)IBA 06/2013
1	Biotin (Vitamin H)FDA Link 08/2011
1	C-Reactive ProteinIBA 08/2011
1	AvidinIBA 08/2011
1	Indicators and Reagents (Reagents)IBA 02/2011
1	Hexosaminidases (Hexosaminidase)IBA 02/2011
1	Acetylglucosaminidase (NAGase)IBA 02/2011
1	alpha-2-HS-GlycoproteinIBA 08/2010
1	AIDS VaccinesIBA 06/2010
1	Broadly Neutralizing AntibodiesIBA 06/2010
1	Contrast MediaIBA 03/2010
1	Interleukin-8 (Interleukin 8)IBA 02/2010
1	Interleukin-18 (Interleukin 18)IBA 02/2010
1	GlycosaminoglycansIBA 02/2010
1	CytokinesIBA 02/2010
1	Warfarin (Coumadin)FDA LinkGeneric 08/2004
1	AnticoagulantsIBA 08/2004
1	GenisteinIBA 01/2004
1	CoumarinsIBA 01/2004
1	Cyclin D1IBA 01/2004
1	7-hydroxycoumarin (umbelliferone)IBA 01/2004
1	coumarinIBA 01/2004

Therapy/Procedure

4	Therapeutics 06/2018 - 01/2004
2	Lasers (Laser) 10/2018 - 01/2015